Healthcare and Lifesciences
VedaCorp advised NU Hospitals, a leading nephrology and urology specialty hospital chain, on its fundraise from National Investment and Infrastructure Fund (NIIF)
About
NU Hospitals
NU Hospitals, incorporated in 1999 and headquartered in Bengaluru, is a leading provider of Nephrology and Urology services. NU Hospitals currently operates hospitals in Bengaluru (3), Shivamogga (1) Ambur (1) and Male, Maldives (1). NU Hospital addresses the rising burden of chronic kidney diseases through a scalable Centre of Excellence model, delivering ethical, affordable, and clinically governed care across nephrology, urology, fertility and renal transplant services. The platform is strengthened by its commitment to medical education and research, advanced robotics enabled surgical capabilities, and multiple quality accreditations including NABH, NABL, FEQH, and ISAR.
NIIF
NIIF is India’s sovereign-anchored alternative asset manager, catalysing global capital to invest in sectors and asset classes that play an important role in India’s growth journey. Anchored by the Government of India in partnership with leading global investors, NIIF manages USD 5+ billion in equity capital commitments across four strategies — Infrastructure, Private Markets, Growth Equity, and Climate Investments.
Background
We are pleased to announce that our client, NU Hospitals Private Limited (“NU Hospitals”) has raised funding from NIIF Private Markets Fund II – managed by National Investment and Infrastructure Fund (“NIIF”). The investment will support NU Hospitals’ next phase of growth, expand access to specialised nephrology and urology care in new markets and strengthen operational capabilities to serve a larger patient base in India as well as overseas.
NU Hospitals, incorporated in 1999 and headquartered in Bengaluru, is a leading provider of Nephrology and Urology services. NU Hospitals currently operates chain of hospitals in Bengaluru, Shivamogga Ambur and Male, Maldives. Its hospitals are NABH accredited and have a strong focus on clinical excellence, medical education and & research.
Veda Corporate Advisors (“VedaCorp”) was the exclusive financial advisor to the NU Hospitals and its shareholders. VedaCorp provided comprehensive transaction advisory services covering identification of prospective investors, strategic positioning, deal structuring and negotiation of key commercial terms leading to the successful closure of the transaction.
This transaction marks VedaCorp’s 11th transaction in healthcare and life sciences segment in the last 12 months. The transaction reinforces VedaCorp’s track record in successfully advising mid-market investments in niche, single-specialty healthcare businesses.